StockData
Accendra Health Inc logo

Accendra Health Inc (ACH) stock

ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.02 (-13.33%)

Close on Nov 13, 2026Market cap $10.00MP/E –Yield –

Accendra Health operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Accendra Health's operating cash flow for the twelve months ending Sep 30, 2026 was -$25.31M. For fiscal 2025 it was -$101.79M, down 163.0% from the year before. The highest annual figure on record is $740.71M in fiscal 2023.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$101.79M-163.0%
FY2024Dec 31, 2024$161.50M-78.2%
FY2023Dec 31, 2023$740.71M+127.9%
FY2022Dec 31, 2022$325.01M+161.7%
FY2021Dec 31, 2021$124.18M-63.4%
FY2020Dec 31, 2020$339.22M+104.2%
FY2019Dec 31, 2019$166.09M+43.7%
FY2018Dec 31, 2018$115.59M+103.6%
FY2017Dec 31, 2017$56.77M-69.8%
FY2016Dec 31, 2016$187.70M-30.5%
FY2015Dec 31, 2015$270.24M–
FY2014Dec 31, 2014-$3.76M-102.7%
FY2013Dec 31, 2013$140.55M-35.7%
FY2012Dec 31, 2012$218.51M+219.4%
FY2011Dec 31, 2011$68.42M-52.2%
FY2010Dec 31, 2010$143.18M-34.3%
FY2009Dec 31, 2009$218.04M+246.8%
FY2008Dec 31, 2008$62.88M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$17.41M–
Q2 FY2026Jun 30, 2026-$26.01M-169.1%
Q1 FY2026Mar 31, 2026-$50.08M–
Q4 FY2025Dec 31, 2025$68.19M-4.0%
Q3 FY2025Sep 30, 2025-$172.52M-731.8%
Q2 FY2025Jun 30, 2025$37.61M-67.6%
Q1 FY2025Mar 31, 2025-$35.07M–
Q4 FY2024Dec 31, 2024$71.00M-36.5%
Q3 FY2024Sep 30, 2024$27.31M-82.7%
Q2 FY2024Jun 30, 2024$116.15M-62.9%
Q1 FY2024Mar 31, 2024-$52.96M-133.4%
Q4 FY2023Dec 31, 2023$111.77M+28.5%
Q3 FY2023Sep 30, 2023$157.44M+129.8%
Q2 FY2023Jun 30, 2023$313.11M+248.6%
Q1 FY2023Mar 31, 2023$158.40M+98.7%
Q4 FY2022Dec 31, 2022$86.96M+72.7%
Q3 FY2022Sep 30, 2022$68.52M+11.5%
Q2 FY2022Jun 30, 2022$89.83M–
Q1 FY2022Mar 31, 2022$79.70M+213.5%
Q4 FY2021Dec 31, 2021$50.34M-29.1%
Q3 FY2021Sep 30, 2021$61.43M-47.8%
Q2 FY2021Jun 30, 2021-$13.02M-122.8%
Q1 FY2021Mar 31, 2021$25.42M-72.8%
Q4 FY2020Dec 31, 2020$71.03M+163.3%
Q3 FY2020Sep 30, 2020$117.74M+6.9%
Q2 FY2020Jun 30, 2020$57.00M-36.6%
Q1 FY2020Mar 31, 2020$93.45M–
Q4 FY2019Dec 31, 2019$26.98M–
Q3 FY2019Sep 30, 2019$110.09M+44.4%
Q2 FY2019Jun 30, 2019$89.92M+221.4%
Q1 FY2019Mar 31, 2019-$60.90M-433.3%
Q4 FY2018Dec 31, 2018-$6.92M-113.5%
Q3 FY2018Sep 30, 2018$76.26M-13.5%
Q2 FY2018Jun 30, 2018$27.98M–
Q1 FY2018Mar 31, 2018$18.27M–
Q4 FY2017Dec 31, 2017$51.13M+18.4%
Q3 FY2017Sep 30, 2017$88.14M–
Q2 FY2017Jun 30, 2017-$56.14M–
Q1 FY2017Mar 31, 2017-$26.36M–
Q4 FY2016Dec 31, 2016$43.18M–

More Accendra Health figures

See a number that looks wrong?